Not a traditional drug phase: Survey Administration for Malignant Vascular Neoplasm
This study looks at the comfort of treatment and diagnostic imaging residents in performing simulated endovascular procedures after completing training on the Mentice endovascular simulator device. Implementation of a training curriculum with radiology residents interested in treatment radiology will help facilitate hands-on training in a low-risk environment and allow for safer future patient encounters.
Official registry: https://clinicaltrials.gov/study/NCT04832698 · M.D. Anderson Cancer Center · enrollment listed as 9
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 9 people at Houston. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training Regimen
Interventions: Survey Administration
Primary outcome (registry wording): Trainees' feelings about using simulation to help with procedural training
Who it is for (from inclusion criteria)
- Ages 18 Years to any
- \- Current treatment and diagnostic radiology residents participating in the training curriculum on the Mentice Endovascular Simulator will be eligible to participate in the survey
Who the registry excludes
- People the protocol lists as excluded — the study team must confirm.
Public study contact (from the registry)
Joshua D Kuban
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
1 listed- M D Anderson Cancer Center — Houston, Texas (recruiting)
FAQ about this NCT record
Is NCT04832698 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT04832698?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT04832698?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary